Literature DB >> 22908571

Inhibitory effect of hexahydrocurcumin on human platelet aggregation.

Huei-Ping Dong1, Rei-Cheng Yang, I-Chun Chunag, Li-Ju Huang, Hsing-Tan Li, Hsin-Liang Chen, Chung-Yi Chen.   

Abstract

The effects of hexahydrocurcumin on adenosine diphosphate (ADP)-induced human platelet aggregation were studied. Treatment of human platelet-rich plasma with hexahydrocurcumin resulted in an inhibitory effect on platelet aggregation, suggesting the potential of this compound as an anti-atherosclerogenic agent in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908571

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  3 in total

1.  Acute and subchronic oral toxicity studies of hydrogenated curcuminoid formulation 'CuroWhite' in rats.

Authors:  Sreeraj Gopi; Joby Jacob; Kotrappa Y Mathur
Journal:  Toxicol Rep       Date:  2016-10-25

2.  The effect of butanolides from Cinnamomum tenuifolium on platelet aggregation.

Authors:  Huei-Ping Dong; Hui-Ming Wu; Sheue-Jiun Chen; Chung-Yi Chen
Journal:  Molecules       Date:  2013-09-25       Impact factor: 4.411

3.  A Toxicological Evaluation of a Standardized Hydrogenated Extract of Curcumin (CuroWhite™).

Authors:  Alastimmanahalli Narasimhiah Ravikumar; Joby Jacob; Sreeraj Gopi; Tumkur Subbarao Jagannath
Journal:  J Toxicol       Date:  2018-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.